Mimedx (MDXG) Notes Payables (2010 - 2011)
Mimedx (MDXG) reported Notes Payables of $1.3 million for Q4 2011, up 221.24% on a YoY basis from $403432.0 in Q4 2010, and up 3365.37% sequentially from $37398.0 in Q3 2011.
Mimedx (MDXG) Notes Payables (2010 - 2011) Analysis & Trends
Mimedx (MDXG) has 2 years of Notes Payables data on file, last reported at $1.3 million in Q4 2011.
- For the quarter ending Q4 2011, Notes Payables rose 221.24% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2011 stood at $1.3 million (up 221.24% YoY), and the FY2011 full-year result was $1.3 million, up 221.24% from the prior year.
- Notes Payables advanced to $1.3 million in Q4 2011, from $37398.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.3 million in Q4 2011 to a low of $37398.0 in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 37,398.00 |
| Jun 30, 2011 | 45,540.00 |
| Dec 31, 2010 | 403,432.00 |